Dogwood Starts Phase 2b Halneuron® Trial For CINP In Early 2025
21 Jan 2025 //
GLOBENEWSWIRE
Dogwood Therapeutics Announces Low Dose IMC-2 Reduces Long-COVID
18 Nov 2024 //
GLOBENEWSWIRE
Dogwood Therapeutics Announces Q3 2024 Financial Results
07 Nov 2024 //
GLOBENEWSWIRE
Dogwood Therapeutics to Report Q3 2024 Results on Nov 7, 2024
31 Oct 2024 //
GLOBENEWSWIRE
Dogwood Therapeutic Regain Compliance with Nasdaq Minimum Bid Price
30 Oct 2024 //
GLOBENEWSWIRE